Hoth Therapeutics (HOTH) Earnings Analysis
Hoth Therapeutics (HOTH) next reports earnings on 2026-09-02, consensus EPS -0.1424 USD. Last quarter (2026-05-15) it missed with EPS -0.17 USD vs -0.1378 USD est (-23.4%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -1.04.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does HOTH next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | -0.1424 USD |
| Revenue estimate | n/a |
HOTH earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -0.17 USD | -0.1378 USD | -23.4% | Miss |
| 2026-03-27 | -0.16 USD | -0.1031 USD | -55.2% | Miss |
| 2025-05-12 | -0.27 USD | -0.34 USD | +20.6% | Beat |
| 2024-08-09 | -0.24 USD | -0.39 USD | +38.5% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
HOTH valuation and analyst view
| Trailing P/E | -1.04 |
|---|---|
| Trailing EPS | -0.73997 USD |
| Price / book | 3.19 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (4 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Hoth Therapeutics (HOTH)'s next earnings date?
Hoth Therapeutics is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -0.1424 USD.
Did HOTH beat earnings last quarter?
In its 2026-05-15 report, HOTH posted EPS of -0.17 USD versus a -0.1378 USD estimate — a miss of 23.4%.
What is HOTH's earnings track record?
Over the last 4 reported quarters with consensus data, HOTH beat estimates 2 times (50%).
What is HOTH's current P/E ratio and EPS?
HOTH trades at a trailing P/E of -1.04 on trailing EPS of -0.739974710519412 USD.
What do analysts rate HOTH?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell).